Agricultural Farm Products
Compare Stocks
5 / 10Stock Comparison
CHSCL vs CF vs MOS vs NTR vs BG
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Inputs
Agricultural Inputs
Agricultural Inputs
Agricultural Farm Products
CHSCL vs CF vs MOS vs NTR vs BG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Agricultural Farm Products | Agricultural Inputs | Agricultural Inputs | Agricultural Inputs | Agricultural Farm Products |
| Market Cap | — | $18.24B | $7.27B | $32.89B | $24.02B |
| Revenue (TTM) | $35.03B | $7.41B | $11.68B | $26.90B | $80.54B |
| Net Income (TTM) | $614M | $1.76B | $1.22B | $2.27B | $686M |
| Gross Margin | 3.2% | 40.4% | 16.5% | 31.1% | 5.2% |
| Operating Margin | 0.2% | 35.7% | 9.9% | 13.4% | 2.4% |
| Forward P/E | — | 8.4x | 15.7x | 12.0x | 14.4x |
| Total Debt | $3.23B | $3.95B | $760M | $12.93B | $16.95B |
| Cash & Equiv. | $399M | $1.98B | $277M | $700M | $1.14B |
CHSCL vs CF vs MOS vs NTR vs BG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CHS Inc. (CHSCL) | 100 | 95.8 | -4.2% |
| CF Industries Holdi… (CF) | 100 | 404.3 | +304.3% |
| The Mosaic Company (MOS) | 100 | 189.5 | +89.5% |
| Nutrien Ltd. (NTR) | 100 | 201.1 | +101.1% |
| Bunge Global S.A. (BG) | 100 | 317.3 | +217.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHSCL vs CF vs MOS vs NTR vs BG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHSCL ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.10, Low D/E 29.1%, current ratio 1.53x
- Beta 0.10 vs MOS's 0.52
CF carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.
- 338.1% 10Y total return vs BG's 140.3%
- PEG 0.19 vs MOS's 0.91
- Lower P/E (8.4x vs 14.4x)
- 23.7% margin vs BG's 0.9%
MOS is the clearest fit if your priority is income & stability.
- Dividend streak 1 yrs, beta 0.52, yield 4.2%
- 4.2% yield, 1-year raise streak, vs NTR's 3.2%, (1 stock pays no dividend)
Among these 5 stocks, NTR doesn't own a clear edge in any measured category.
BG is the #2 pick in this set and the best alternative if growth exposure and defensive is your priority.
- Rev growth 32.4%, EPS growth -38.4%, 3Y rev CAGR 1.5%
- Beta 0.25, yield 2.2%, current ratio 1.61x
- 32.4% revenue growth vs CHSCL's -9.7%
- +66.8% vs MOS's -24.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.4% revenue growth vs CHSCL's -9.7% | |
| Value | Lower P/E (8.4x vs 14.4x) | |
| Quality / Margins | 23.7% margin vs BG's 0.9% | |
| Stability / Safety | Beta 0.10 vs MOS's 0.52 | |
| Dividends | 4.2% yield, 1-year raise streak, vs NTR's 3.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +66.8% vs MOS's -24.6% | |
| Efficiency (ROA) | 12.4% ROA vs BG's 1.6%, ROIC 18.7% vs 3.3% |
CHSCL vs CF vs MOS vs NTR vs BG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CHSCL vs CF vs MOS vs NTR vs BG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CF leads in 3 of 6 categories
CHSCL leads 0 • MOS leads 0 • NTR leads 0 • BG leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CF leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BG is the larger business by revenue, generating $80.5B annually — 10.9x CF's $7.4B. CF is the more profitable business, keeping 23.7% of every revenue dollar as net income compared to BG's 0.9%. On growth, BG holds the edge at +87.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $35.0B | $7.4B | $11.7B | $26.9B | $80.5B |
| EBITDAEarnings before interest/tax | $471M | $3.5B | $2.2B | $6.0B | $2.8B |
| Net IncomeAfter-tax profit | $614M | $1.8B | $1.2B | $2.3B | $686M |
| Free Cash FlowCash after capex | $280M | $1.6B | -$535M | $2.0B | $112M |
| Gross MarginGross profit ÷ Revenue | +3.2% | +40.4% | +16.5% | +31.1% | +5.2% |
| Operating MarginEBIT ÷ Revenue | +0.2% | +35.7% | +9.9% | +13.4% | +2.4% |
| Net MarginNet income ÷ Revenue | +1.8% | +23.7% | +10.5% | +8.4% | +0.9% |
| FCF MarginFCF ÷ Revenue | +0.8% | +21.9% | -4.6% | +7.4% | +0.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.6% | +19.4% | -7.5% | +6.8% | +87.8% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +115.1% | +3.8% | +4.2% | -76.4% |
Valuation Metrics
Evenly matched — CF and MOS each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 5.9x trailing earnings, MOS trades at a 77% valuation discount to BG's 25.2x P/E. Adjusting for growth (PEG ratio), CF offers better value at 0.30x vs NTR's 0.35x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | — | $18.2B | $7.3B | $32.9B | $24.0B |
| Enterprise ValueMkt cap + debt − cash | — | $20.2B | $7.8B | $45.1B | $39.8B |
| Trailing P/EPrice ÷ TTM EPS | — | 13.24x | 5.90x | 14.42x | 25.16x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 8.41x | 15.68x | 12.01x | 14.38x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.30x | 0.34x | 0.35x | — |
| EV / EBITDAEnterprise value multiple | — | 6.19x | 3.59x | 7.08x | 22.60x |
| Price / SalesMarket cap ÷ Revenue | — | 2.57x | 0.62x | 1.20x | 0.34x |
| Price / BookPrice ÷ Book value/share | — | 2.48x | 0.55x | 1.31x | 1.18x |
| Price / FCFMarket cap ÷ FCF | — | 10.12x | — | 16.15x | — |
Profitability & Efficiency
CF leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CF delivers a 22.3% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $4 for BG. MOS carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to BG's 0.97x. On the Piotroski fundamental quality scale (0–9), CF scores 8/9 vs BG's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.5% | +22.3% | +10.0% | +9.1% | +4.3% |
| ROA (TTM)Return on assets | +3.0% | +12.4% | +5.0% | +4.3% | +1.6% |
| ROICReturn on invested capital | +0.5% | +18.7% | +6.1% | +8.0% | +3.3% |
| ROCEReturn on capital employed | +0.7% | +18.3% | +5.9% | +9.8% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 8 | 7 | 8 | 2 |
| Debt / EquityFinancial leverage | 0.29x | 0.51x | 0.06x | 0.51x | 0.97x |
| Net DebtTotal debt minus cash | $2.8B | $2.0B | $483M | $12.2B | $15.8B |
| Cash & Equiv.Liquid assets | $399M | $2.0B | $277M | $700M | $1.1B |
| Total DebtShort + long-term debt | $3.2B | $3.9B | $760M | $12.9B | $17.0B |
| Interest CoverageEBIT ÷ Interest expense | 5.03x | 16.31x | 8.81x | 5.44x | 3.10x |
Total Returns (Dividends Reinvested)
CF leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CF five years ago would be worth $23,091 today (with dividends reinvested), compared to $7,211 for MOS. Over the past 12 months, BG leads with a +66.8% total return vs MOS's -24.6%. The 3-year compound annual growth rate (CAGR) favors CF at 22.6% vs MOS's -12.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.0% | +48.8% | -7.6% | +9.1% | +34.4% |
| 1-Year ReturnPast 12 months | +7.4% | +49.6% | -24.6% | +24.6% | +66.8% |
| 3-Year ReturnCumulative with dividends | +22.2% | +84.1% | -32.7% | +16.0% | +46.3% |
| 5-Year ReturnCumulative with dividends | +21.4% | +130.9% | -27.9% | +28.1% | +49.4% |
| 10-Year ReturnCumulative with dividends | +59.2% | +338.1% | +14.9% | +54.0% | +140.3% |
| CAGR (3Y)Annualised 3-year return | +6.9% | +22.6% | -12.4% | +5.1% | +13.5% |
Risk & Volatility
Evenly matched — CHSCL and CF each lead in 1 of 2 comparable metrics.
Risk & Volatility
CF is the less volatile stock with a -0.62 beta — it tends to amplify market swings less than MOS's 0.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHSCL currently trades 98.5% from its 52-week high vs MOS's 59.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.10x | -0.62x | 0.52x | -0.07x | 0.25x |
| 52-Week HighHighest price in past year | $26.10 | $141.96 | $38.23 | $85.36 | $133.93 |
| 52-Week LowLowest price in past year | $25.15 | $75.42 | $22.74 | $53.03 | $71.60 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +83.6% | +59.9% | +80.1% | +92.4% |
| RSI (14)Momentum oscillator 0–100 | 57.0 | 47.0 | 42.7 | 48.9 | 51.8 |
| Avg Volume (50D)Average daily shares traded | 26K | 4.9M | 9.5M | 3.8M | 1.7M |
Analyst Outlook
Evenly matched — MOS and NTR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CF as "Buy", MOS as "Hold", NTR as "Buy", BG as "Buy". Consensus price targets imply 36.4% upside for MOS (target: $31) vs -8.3% for CF (target: $109). For income investors, MOS offers the higher dividend yield at 4.15% vs CF's 1.69%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $108.89 | $31.25 | $84.25 | $133.67 |
| # AnalystsCovering analysts | — | 41 | 49 | 33 | 25 |
| Dividend YieldAnnual dividend ÷ price | — | +1.7% | +4.2% | +3.2% | +2.2% |
| Dividend StreakConsecutive years of raises | — | 0 | 1 | 8 | 5 |
| Dividend / ShareAnnual DPS | — | $2.01 | $0.95 | $2.22 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | — | 0.0% | 0.0% | +1.7% | +2.3% |
CF leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 3 categories are tied.
CHSCL vs CF vs MOS vs NTR vs BG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CHSCL or CF or MOS or NTR or BG a better buy right now?
For growth investors, Bunge Global S.
A. (BG) is the stronger pick with 32. 4% revenue growth year-over-year, versus -9. 7% for CHS Inc. (CHSCL). The Mosaic Company (MOS) offers the better valuation at 5. 9x trailing P/E (15. 7x forward), making it the more compelling value choice. Analysts rate CF Industries Holdings, Inc. (CF) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHSCL or CF or MOS or NTR or BG?
On trailing P/E, The Mosaic Company (MOS) is the cheapest at 5.
9x versus Bunge Global S. A. at 25. 2x. On forward P/E, CF Industries Holdings, Inc. is actually cheaper at 8. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CF Industries Holdings, Inc. wins at 0. 19x versus The Mosaic Company's 0. 91x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CHSCL or CF or MOS or NTR or BG?
Over the past 5 years, CF Industries Holdings, Inc.
(CF) delivered a total return of +130. 9%, compared to -27. 9% for The Mosaic Company (MOS). Over 10 years, the gap is even starker: CF returned +338. 1% versus MOS's +14. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHSCL or CF or MOS or NTR or BG?
By beta (market sensitivity over 5 years), CF Industries Holdings, Inc.
(CF) is the lower-risk stock at -0. 62β versus The Mosaic Company's 0. 52β — meaning MOS is approximately -183% more volatile than CF relative to the S&P 500. On balance sheet safety, The Mosaic Company (MOS) carries a lower debt/equity ratio of 6% versus 97% for Bunge Global S. A. — giving it more financial flexibility in a downturn.
05Which is growing faster — CHSCL or CF or MOS or NTR or BG?
By revenue growth (latest reported year), Bunge Global S.
A. (BG) is pulling ahead at 32. 4% versus -9. 7% for CHS Inc. (CHSCL). On earnings-per-share growth, the picture is similar: The Mosaic Company grew EPS 605. 5% year-over-year, compared to -38. 4% for Bunge Global S. A.. Over a 3-year CAGR, BG leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CHSCL or CF or MOS or NTR or BG?
CF Industries Holdings, Inc.
(CF) is the more profitable company, earning 20. 5% net margin versus 1. 2% for Bunge Global S. A. — meaning it keeps 20. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CF leads at 33. 4% versus 0. 3% for CHSCL. At the gross margin level — before operating expenses — CF leads at 38. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CHSCL or CF or MOS or NTR or BG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, CF Industries Holdings, Inc. (CF) is the more undervalued stock at a PEG of 0. 19x versus The Mosaic Company's 0. 91x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, CF Industries Holdings, Inc. (CF) trades at 8. 4x forward P/E versus 15. 7x for The Mosaic Company — 7. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MOS: 36. 4% to $31. 25.
08Which pays a better dividend — CHSCL or CF or MOS or NTR or BG?
In this comparison, MOS (4.
2% yield), NTR (3. 2% yield), BG (2. 2% yield), CF (1. 7% yield) pay a dividend. CHSCL does not pay a meaningful dividend and should not be held primarily for income.
09Is CHSCL or CF or MOS or NTR or BG better for a retirement portfolio?
For long-horizon retirement investors, CF Industries Holdings, Inc.
(CF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 62), 1. 7% yield, +338. 1% 10Y return). Both have compounded well over 10 years (CF: +338. 1%, CHSCL: +59. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CHSCL and CF and MOS and NTR and BG?
These companies operate in different sectors (CHSCL (Consumer Defensive) and CF (Basic Materials) and MOS (Basic Materials) and NTR (Basic Materials) and BG (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CHSCL is a small-cap quality compounder stock; CF is a mid-cap high-growth stock; MOS is a small-cap deep-value stock; NTR is a mid-cap deep-value stock; BG is a mid-cap high-growth stock. CF, MOS, NTR, BG pay a dividend while CHSCL does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Consumer Defensive
- Market Cap > $100B
- Revenue Growth > 43%
- Dividend Yield > 0.8%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.